drugset / Trial / NCT02445456
Feasibility of Sentinel Lymph Node Biopsy in Rectal Cancer
Terminated
15 enrolled
Oxford University Hospitals NHS Trust
Endomagnetics Inc · collabUniversity of Leeds · collab
Non-randomizedParallel-groupOpen-labelDiagnostic
Summary
This study will assess whether the Sienna+/Sentimag system, which involves a magnetic tracer, is effective in identifying the sentinel lymph node in rectal cancer and whether it is then feasible to remove this lymph node during surgery to locally excise early rectal cancer.
Timeline
- Start
- 2016-12
- Primary completion
- 2020-12
- Completion
- 2020-12
Outcome
Outcome not reported
Stopped (Enrollment): “Logistical difficulties in recruiting patients led to slower than expected recruitment. Recruitment was completely suspended during Covid and will not be restarted.”
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Sienna+ | Unknown | — | Other |